Xofigo Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Radium-223 dichloride

Indications/Uses

Castration-resistant prostate cancer patients w/ symptomatic bone metastases & no known visceral metastatic disease.

Dosage/Direction for Use

IV 55 kBq/kg given at 4 wk intervals for 6 inj.

Contraindications

In combination w/ abiraterone acetate & prednisone/prednisolone.

MIMS Class

Targeted Cancer Therapy

ATC Classification

V10XX03 - radium (223Ra) dichloride ; Belongs to the class of various therapeutic radiopharmaceuticals.

Regulatory Classification

POM

Presentation/Packing

Form

Xofigo soln for inj 1,100 kBq/mL

Packing/Price

1's

Xofigo

Manufacturer:

Agilera Pharma